Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Stage IV Large Cell Lung Carcinoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00550537
What this trial is testing

Proteomic Profiling in Predicting Response in Patients Receiving Erlotinib for Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
Vanderbilt-Ingram Cancer Center 116
Testing effectiveness (Phase 2)Study completedNCT00118183
What this trial is testing

Docetaxel With Either Cetuximab or Bortezomib as First-Line Therapy in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer

Who this might be right for
Adenocarcinoma of the LungAdenosquamous Cell Lung CancerLarge Cell Lung Cancer+5 more
National Cancer Institute (NCI) 62
Testing effectiveness (Phase 2)Ended earlyNCT00754923
What this trial is testing

Sorafenib in Treating Non-Smokers or Former Light Smokers With Relapsed or Refractory Stage IIIB or Stage IV Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
Ohio State University Comprehensive Cancer Center 11
Large-scale testing (Phase 3)Study completedNCT00014391
What this trial is testing

Ribavirin With or Without Monoclonal Antibody Therapy in Treating Patients Who Develop RSV Pneumonia Following Peripheral Stem Cell Transplantation

Who this might be right for
Cancer
Fred Hutchinson Cancer Center
Not applicableStudy completedNCT03998332
What this trial is testing

Overall Survival of Large Cell Neuroendocrine Lung Cancer Patients - a Retrospective Study

Who this might be right for
Survival Outcomes of Patients With Pulmonary LCNEC
Jaroslaw B. Cwikla, MD, PhD, Professor UWM 132
Post-approval studies (Phase 4)Study completedNCT01317615
What this trial is testing

RAD001 With Paclitaxel and Carboplatin in First Line Treatment of Patients With Advanced Large Cell Lung Cancer With Neuroendocrine Differentiation

Who this might be right for
Carcinoma, Large CellNeuroendocrine Tumors
Novartis Pharmaceuticals 49
Testing effectiveness (Phase 2)Study completedNCT00036920
What this trial is testing

TLK286 in Treating Patients With Advanced Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
Memorial Sloan Kettering Cancer Center
Early research (Phase 1)Study completedNCT00003022
What this trial is testing

Monoclonal Antibody Therapy in Treating Patients With Leptomeningeal Cancer

Who this might be right for
Brain and Central Nervous System TumorsIntraocular MelanomaLung Cancer+4 more
Memorial Sloan Kettering Cancer Center
Testing effectiveness (Phase 2)Ended earlyNCT00776100
What this trial is testing

Radiation Therapy or Observation After Chemotherapy in Treating Patients With Stage IV Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
Alliance for Clinical Trials in Oncology 3
Testing effectiveness (Phase 2)Ended earlyNCT03713944
What this trial is testing

Carboplatin Plus Pemetrexed Plus Atezolizumab Plus Bevacizumab in Chemotherapy and Immunotherapy-naïve Patients With Stage IV Non-squamous Non-small Cell Lung Cancer

Who this might be right for
NSCLC Stage IVNSCLC, Recurrent
Nasser Hanna 30
Testing effectiveness (Phase 2)Ended earlyNCT00438204
What this trial is testing

Pemetrexed Disodium, Gemcitabine, and Bevacizumab in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
Barbara Ann Karmanos Cancer Institute 39
Early research (Phase 1)Study completedNCT00020579
What this trial is testing

MS-275 in Treating Patients With Advanced Solid Tumors or Lymphoma

Who this might be right for
Cancer
National Institutes of Health Clinical Center (CC) 75
Testing effectiveness (Phase 2)Study completedNCT01344824
What this trial is testing

Carboplatin, Pemetrexed Disodium, and Bevacizumab for Patients With Stage III or IV Non-Small Cell Lung Cancer Who Are Light/Never Smokers

Who this might be right for
Lung Cancer
UNC Lineberger Comprehensive Cancer Center 38
Testing effectiveness (Phase 2)Study completedNCT03845296
What this trial is testing

Rucaparib in Treating Patients With Genomic LOH High and/or Deleterious BRCA1/2 Mutation Stage IV or Recurrent Non-small Cell Lung Cancer (A Lung-MAP Treatment Trial)

Who this might be right for
Deleterious BRCA1 Gene MutationDeleterious BRCA2 Gene MutationLoss of Heterozygosity+8 more
SWOG Cancer Research Network 64
Large-scale testing (Phase 3)UnknownNCT00955695
What this trial is testing

Radiation Therapy to the Brain or Observation in Preventing Brain Metastases in Patients With Advanced Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
National Cancer Center, Korea 242
Testing effectiveness (Phase 2)Study completedNCT00425646
What this trial is testing

Imatinib Mesylate and Bevacizumab After First-Line Chemotherapy and Bevacizumab in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
University of Washington 50
Testing effectiveness (Phase 2)Study completedNCT03728361
What this trial is testing

Nivolumab and Temozolomide in Treating Patients With Recurrent or Refractory Small-Cell Lung Cancer or Advanced Neuroendocrine Cancer

Who this might be right for
Grade I Neuroendocrine CarcinomaGrade II Neuroendocrine CarcinomaGrade III Neuroendocrine Carcinoma+9 more
Dwight Owen 55
Testing effectiveness (Phase 2)Ended earlyNCT00528775
What this trial is testing

Photodynamic Therapy Using HPPH in Treating Patients With Advanced Non-Small Cell Lung Cancer That Blocks the Air Passages

Who this might be right for
Lung Cancer
Roswell Park Cancer Institute 6
Testing effectiveness (Phase 2)UnknownNCT00003562
What this trial is testing

Docetaxel Plus Carboplatin in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer

Who this might be right for
Lung Cancer
Hope Cancer Institute, Inc. 38
Large-scale testing (Phase 3)Study completedNCT00003117
What this trial is testing

Paclitaxel With or Without Carboplatin in Treating Patients With Advanced Non-small Cell Lung Cancer

Who this might be right for
Lung Cancer
Alliance for Clinical Trials in Oncology 584
Next Page